PEDIA-LAX ENEMA OTC
Generic Name and Formulations:
Monobasic sodium phosphate 9.5g, dibasic sodium phosphate 3.5g; per 59mL; latex-free; contains 2.2g sodium per enema.
Fleet, C.B., Company
Indications for PEDIA-LAX ENEMA:
Occasional constipation or bowel cleansing before rectal exam.
<2yrs: do not use. 2–4yrs: ½ enema rectally. 5–11yrs: 1 enema rectally. Results usually in 1–5 min; reevaluate if ineffective.
CHF. Ascites. Severe renal impairment. GI or GU obstruction. Megacolon. Imperforate anus.
Sodium-restricted diet. Impaired renal or cardiac function. Electrolyte disturbances. Colostomy. Discontinue if rectal bleeding or if no bowel movement occurs. Frequent use leads to dependence.
Electrolyte imbalances possible with calcium channel blockers, diuretics; use cautiously.
Endocrinology Advisor Articles
- Use of In-Hospital Continuous Subcutaneous Insulin Infusion: A Consensus Statement
- Better Control With DPP-4 Inhibitors vs NPH Insulin in Type 2 Diabetes
- Achieving Glycemic Control in T2D After Basal Insulin Initiation
- Osteoporosis Drug Shows Cardioprotective Potential at 10-Year Follow-Up
- Effects of the Two Types of Anorexia Nervosa on Bone Metabolism
- Diabetes Treatments
- Incretins, Thiazolidinediones Associated With Better Glycemic Control in T2D
- No Link Between HbA1c Levels and Wound Healing in Patients With Diabetic Foot Ulcers
- Risk for Fetal Loss Early in Pregnancy Not Greater With Noninsulin vs Insulin Therapy
- Risk for Iodine Deficiency and Hypothyroidism High in Children on Parenteral Nutrition
- Inverse Association Between Serum 25(OH)D Levels and Risk for Diabetes
- Glycemic Control Variations for Children, Adolescents With T1D in High-Income Countries
- Late-Life Mobility Limitations Linked to Obesity After Arthroplasty for OA in Women
- Fracture Risk Should Be Monitored in Bisphosphonate Drug Holiday
- Provider Counseling for Weight Loss Up for Arthritis, Overweight